Kiniksa Pharmaceuticals International, plc
KNSA
Classificação em ações
#2917
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Preço da ação
$80.10
Última sincronização: 2026-10-21
Valor de mercado
$6.25B
Variação (1 dia)
-3.69%
Variação (1 ano)
105.92%
País
GB
Negociar Kiniksa Pharmaceuticals International, plc (KNSA)
Categoria
Healthcare
Histórico de preços das ações de Kiniksa Pharmaceuticals International, plc (KNSA)
Preço de fecho mais alto: $78.59 em 2026-10-01
Preço de fecho mais baixo: $18.08 em 2018-05-01
Preço de fecho mais baixo: $18.08 em 2018-05-01
Histórico de preços das ações da Kiniksa Pharmaceuticals International, plc de 2018 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | 31.83% |
| 2025 | 101.55% |
| 2024 | 16.14% |
| 2023 | 13.98% |
| 2022 | 22.63% |
| 2021 | -31.53% |
| 2020 | 57.49% |
| 2019 | -47.95% |
| 2018 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $62.20 | 68.82% |
US
|
|
| $45.29 | 34.87% |
SE
|
|
| $170.92 | 23.58% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
